Literature DB >> 24395363

FX cloning: a simple and robust high-throughput cloning method for protein expression.

Eric R Geertsma1.   

Abstract

The immense amount of gene sequences available nowadays allows scientist to screen broadly for extraordinary proteins. Reliable cloning tools that allow the parallel processing of many targets are vital for the success of this strategy. The FX cloning procedure detailed here is such a straightforward and efficient tool. It is dedicated to the cloning of open reading frames (ORFs) with the final aim of expressing the corresponding proteins. FX cloning combines attractive features of established high-throughput cloning methods that were thus far not unified in one single method. It facilitates the subcloning of a sequence-verified ORF to a variety of expression vectors, but is sufficiently versatile to accept PCR products as well. Moreover, the common, but undesirable feature of extending target ORFs with long cloning-related sequences is avoided. It leads to the addition of only one amino acid to each side of the protein. As a consequence, only one primer pair or PCR product suffices to generate expression vectors for both N- and C-terminal translational fusions. FX cloning is highly efficient and economical in its use. The method is suited for high-throughput cloning projects and also for everyday cloning of single targets. FX cloning is based on the use of type IIS restriction enzymes and negative selection markers. The full procedure takes place in one pot in less than 3 h and does not require intermediate purification steps nor extensive handling. The method has proven to be very robust and suitable for all common expression systems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24395363     DOI: 10.1007/978-1-62703-764-8_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Charge Interactions Can Dominate Coupled Folding and Binding on the Ribosome.

Authors:  Jacopo Marino; Karin J Buholzer; Franziska Zosel; Daniel Nettels; Benjamin Schuler
Journal:  Biophys J       Date:  2018-08-15       Impact factor: 4.033

2.  Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.

Authors:  Ole Niewoehner; Carmela Garcia-Doval; Jakob T Rostøl; Christian Berk; Frank Schwede; Laurent Bigler; Jonathan Hall; Luciano A Marraffini; Martin Jinek
Journal:  Nature       Date:  2017-07-19       Impact factor: 49.962

3.  Mistic's membrane association and its assistance in overexpression of a human GPCR are independent processes.

Authors:  Jacopo Marino; Natalie Bordag; Sandro Keller; Oliver Zerbe
Journal:  Protein Sci       Date:  2014-10-25       Impact factor: 6.725

4.  Generation of synthetic nanobodies against delicate proteins.

Authors:  Iwan Zimmermann; Pascal Egloff; Cedric A J Hutter; Benedikt T Kuhn; Philipp Bräuer; Simon Newstead; Roger J P Dawson; Eric R Geertsma; Markus A Seeger
Journal:  Nat Protoc       Date:  2020-04-08       Impact factor: 13.491

5.  The force-sensing peptide VemP employs extreme compaction and secondary structure formation to induce ribosomal stalling.

Authors:  Ting Su; Jingdong Cheng; Daniel Sohmen; Rickard Hedman; Otto Berninghausen; Gunnar von Heijne; Daniel N Wilson; Roland Beckmann
Journal:  Elife       Date:  2017-05-30       Impact factor: 8.140

6.  A uniform cloning platform for mycobacterial genetics and protein production.

Authors:  Fabian M Arnold; Michael Hohl; Sille Remm; Hendrik Koliwer-Brandl; Sophia Adenau; Sasitorn Chusri; Peter Sander; Hubert Hilbi; Markus A Seeger
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.